Conference Presentations

Oral Presentations

Postponed Conferences

9th International Conference on Hepatitis Care in Substance Users (Postponed to late 2021)

The impact of direct acting antiviral treatments on all-cause and drug related mortality in a large population based cohort study
Increased hepatitis screening and diagnosis after transfer of health care responsibility to public health system in British Columbia correctional centres
Classes of people initiating chronic prescription opioid therapy and association with daily morphine equivalent dose

Western Canadian Universities Big Data Health Conference (WCUC) (Date TBD)

Population-level precision medicine: a latent class analysis of people living with hepatitis C virus for targeted program planning

2024

Nov 15-19, 2024 American Association for the Study of Liver Diseases, San Diego, CA

Impact of COVID-19-related public health measures on treatment for hepatitis B in British Columbia, Canada: an interrupted time series analysis

Injection related infections among people living with hepatitis C across pre and post treatment phases.

Jun 5-9, 2024 Annual International Liver Congress organized by the European Association for the Study of the Liver (EASL), Milan, Italy

Disparities in hepatocellular carcinoma survival among people with hepatitis B or hepatitis C virus infection in Canada Mortality risk following HCV cure among people with HIV coinfection

Burden of extrahepatic manifestations after HCV cure: assessing the effect of IFN versus DAA-induced SVR in a large population-based cohort in British Columbia, Canada

February 27-March 3, 2024 Joint CDDWTM-CLM Conference, Toronto, ON

Ethnic disparity in mortality related to extrahepatic manifestations among people with chronic HCV infection: a large, linked administrative population-based study in British Columbia, Canada
The impact of covid-19-related public health measures on hepatocellular carcinoma screening in British Columbia, Canada: an interrupted time series study
Assessing the impact of HCV treatment on extrahepatic manifestations using administrative data

2023

Nov 10-14, 2023 American Association for the Study of Liver Diseases, Boston, MA

Impact of COVID-19-related public health measures on hepatitis C treatment initiation in British Columbia, Canada: an interrupted time series analysis

Impact of COVID-19-related public health measures on testing for hepatitis B in British Columbia, Canada: an interrupted time series analysis

Ethnic Disparities in HCV-related Extrahepatic Manifestations: A Population-Based Study in British Columbia, Canada

Sept 29 – Oct 1, 2023 CASL Single Topic Conference on Progress toward Hepatitis B Elimination Meeting in Canada

Effect of hepatitis B virus treatment on all-cause and liver-related death among individuals with HBV and cirrhosis in British Columbia: a population-based cohort study

Jun 21–24, 2023 Annual International Liver Congress organized by the European Association for the Study of the Liver (EASL), Vienna, Austria

The impact of Covid-19 on hepatocellular carcinoma screening in British Columbia, Canada

Mortality risk following HCV cure among people with HIV coinfection

Ethnic disparity in mortality related to extrahepatic manifestations among people with chronic HCV infection: a large, linked administrative population-based study in British Columbia, Canada

March 3-5, 2023 Joint CDDWTM-CLM Conference, Halifax, NS

The first provincial correctional system-wide hepatitis C care cascade in Canada: Monitoring hepatitis C care in British Columbia provincial correctional centres

Risk of COVID-19 severe outcomes among people with cirrhosis: A population-based cohort study in Canada

Effect of DAA treatment on extrahepatic manifestations incidence: A population-based study in British Columbia, Canada

Population-level assessment of hepatitis C virus sero-prevalence among people experiencing unstable housing in British Columbia

February 19-22, 2023 Conference on Retroviruses and Opportunistic Infections, Seattle, WA

Syndemic of chronic viral infections on the risk of end-stage renal disease

2022

Nov 4-8, 2022 American Association for the Study of Liver Diseases

Effect of DAA treatment on extrahepatic manifestations incidence: a population-based study in British Columbia, Canada
The impact of direct-acting antiviral treatment for HCV on hepatocellular carcinoma risk in a large population-based cohort study

Oct 19-21, 2022 International Conference of Health and Hepatitis Care in Substance Users

Hepatitis C virus prevalence from 2010-2015 among people experiencing unstable housing in a population-based data linkage study

Jun 22–26, 2022 Annual International Liver Congress organized by the European Association for the Study of the Liver (EASL)

Excess mortality risk among Hepatitis C patients after being "cured" in the interferon-free era: results from three population-based cohorts
Effect of Hepatitis B virus treatment on all causes and liver-related death among patients living with HBV with cirrhosis in British Columbia, Canada in a population-based cohort study
The HCV care cascade for children and young people in British Columbia, Canada: a large, linked administrative population-based cohort study
Impact of Hepatitis B virus infection on liver-related death among people tested for HBC in British Columbia, Canada: results from a large longitudinal population-based cohort study
The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada

May 13-15, 2022 Canadian Liver Meeting (Virtual Meeting)

Impact of Hepatitis B virus infection, non-alcoholic fatty liver disease and coinfection with Hepatitis C virus on liver-related death among people tested for Hepatitis B virus in British Columbia: results form a large longitudinal population-based cohort study
Effect of Hepatitis B virus treatment on all causes and liver-related death among patients living with HBV with cirrhosis in British Columbia, Canada in a population-based cohort study
The 2020 HCV cascade of care for children an youth in British Columbia, Canada
The impact of the Covid-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada

2021

Nov 12-15, 2021 American Association for the Study of Liver Diseases (Digital Conference)

The 2019 HCV cascade of care for children and youth in British Columbia, Canada
Benefits of DAA treatment on mortality related extrahepatic manifestations among people who inject drugs: a population-based study in British Columbia, Canada
Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in Canada
Chronic hepatitis C infection and incidence of extrahepatic cancers in a Canadian population-based cohort
NAFLD and NASH (Epidemiology and Natural History, Prevention and Outcomes)
Hepatitis C screening and diagnosis in a Canadian provincial correctional system during the Covid-19 pandemic

Oct 13-15, 2021 International Network on Health and Hepatitis in Substance Users

Impact of direct-acting antiviral treatment on mortality related to extrahepatic manifestations: Findings from a large population-based cohort in British Columbia, Canada
Increased Hepatitis C screening and diagnosis after transfer of health care responsibility to public health system in correctional centres in British Columbia, Canada

June 23-26, 2021 Annual International Liver Congress organized by the European Association for the Study of the Liver (EASL) (Virtual Conference)

Mortality risk following HCV cure among people with HVC coinfection
Impact of direct-acting antiviral treatment on mortality related to extrahepatic manifestations: findings from a large population-based cohort in British Columbia, Canada

May 2-5, 2021 Canadian Liver Meeting (Virtual Meeting)

Mortality risk following HCV cure among people with HCV/HIV Coinfection
Impact of Covid-19 related public health measures on HCV testing in British Columbia, Canada: an interrupted time series analysis
Impact of Covid-19 related restrictions on HCV testing in British Columbia, Canada

2020

Nov 13-16, 2020, American Association for the Study of Liver Diseases (Digital Conference)

Continued inequities in the hepatitis C cascade of care experiences by people who inject drugs in BC in 2019: a population-level linked data study
The impact of direct acting antiviral treatments on all-cause, liver, and drug related mortality in a large population-based cohort study
Women and the hepatitis C cascade of care in 2019: findings from the BC Hepatitis Testers Cohort

Aug 27-29, 2020, 55th Annual International Liver Congress organized by the European Association for the Study of the Liver (EASL) (Digital Conference)

A latent class analysis to characterizing multivariable profiles of people living with Hepatitis C virus at a population level
Population-level hepatitis C cascade of care among men who have sex with men in British Columbia, Canada
Incidence of HCV infection among gbMSM in British Columbia, Canada: a population-based cohort study
All-cause mortality and liver-related death following entecavir, tenofovir disoproxil fumarate or lamivudine therapy among treatment naive chronic hepatitis B patients in British Columbia, Canada
Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment
Ethnic disparities in the risk of hepatitis C virus-related diabetes in a large population-based cohort in Canada
Frequency of Prenatal Hepatitis C Screening and Diagnoses in British Columbia, 2008-2018

Jul 20-24, 2020, 33rd International Papillomavirus Conference (Digital Conference)

The incidence of anal squamous cell carcinoma by HIV and MSM status in British Columbia, Canada (1990-2015)
Incidence rates for oropharyngeal and oral cavity cancers among HIV-positive and HIV-negative individuals in British Columbia, Canada: a retrospective cohort study

Jul 6-10, 2020, 23rd International AIDS Conference (Digital Conference)

Incidence rates of anal squamous cell carcinoma among HIV-positive and HIV-negative individuals by MSM status in British Columbia, Canada: a retrospective cohort study (1990-2015)
The incidence of oropharyngeal and oral cavity cancers by HIV and MSM status in British Columbia, Canada (1990-2015)

Apr 30-May 3, 2020, 29th Annual Canadian Conference on HIV/AIDS Research (CAHR) (Digital Conference)

Using population-level latent class analysis to classify people living with HCV in British Columbia (BC) for targeted program planning
Incidence rates for oropharyngeal and oral cavity cancers among HIV-positive and HIV-negative individuals in British Columbia, Canada: a retrospective cohort study
The incidence of anal squamous cell carcinoma by HIV and MSM status in British Columbia, Canada (1990-2015)
Incidence of HCV infection among gbMSM in British Columbia, Canada: a population based cohort study

Mar 8-11, 2020, Conference on Retroviruses and Opportunistic Infections (Digital Conference)

Syndemic of viral co-infections and incident end-stage renal disease

Mar 4-8, 2020, Asian Pacific Association for the Study of the Liver (Bali, Indonesia)

Assessing the ethnic disparities in the HCV-related type 2 diabetes in an ethnically diverse large population-based cohort in British Columbia, Canada
All-cause mortality and liver-related death following entecavir, tenofovir disoproxil fumarate or lamivudine therapy among treatment-naive chronic hepatitis B patients in British Columbia, Canada

Feb 28-Mar 1, 2020 Canadian Liver Meeting (Montreal, QC)

The combined effect of sustained virologic response and opioid agonist therapy on cause-specific mortality among people living with chronic hepatitis C
Increasing hepatitis C screening & new diagnoses in 10 British Columbia Provincial Correctional Centres from 2010-2019

2019

Nov 25-27, 2019 Canadian Centre on Substance Use and Addiction's 2019 Issues of Substance Use Conference (Ottawa, ON)

Chronic prescription opioid therapy associated with injection drug use: A large administrative cohort study

Nov 9-12, 2019 American Association for the Study of Liver Disease (Boston, MA)

Hepatitis C virus reinfection after successful treatment with direct acting antiviral therapy in Canada

Nov 3-5, 2019 5th Canadian Cancer Research Conference (Ottawa, ON)

Syndemics of HCV, HBV and HIV (co)infections on Colorectal and anal cancers: A population-based cohort study

Sep 11-13, 2019 8th International Conference on Hepatitis Care in Substance Users (Montreal, QC)

Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in Canada
Recent opioid agonist therapy and hepatitis C virus treatment uptake among people who inject drugs with chronic hepatitis C infection in a population based data linkage study

Jul 14-17, 2019 23rd International Society for Sexually Transmitted Diseases Research (Vancouver, BC)

Hepatitis C incidence rate among people who inject drug (PWID) in British Columbia from 2000 to 2015

May 9-12, 2019 28th Annual Canadian Conference on HIV/AIDS Research (Saskatoon, SK)

HCV, HBV and HIV syndemics are associated with higher mortality risk in a large population based cohort study
Effectiveness of sofosbuvir / velpatasvir in treating hepatitis C virus infection in real- world setting
Elevated HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men

Mar 4-7, 2019 Conference on Retroviruses and Opportunistic Infections (Seattle, WA)

Syndemic Viral Co-Infections and Incident Cerebrovascular and End-Stage Renal Disease (accepted but not presented)
Survival After End-Stage Renal Disease Diagnosis in HCV-Infected Patients (accepted but not presented)

2018

Nov 9-14, 2018 American Association for the Study of Liver Disease (San Francisco, CA)

Space- Time Clustering of HCV Reinfections to Inform Local Interventions for Prevention of Reinfection
Effectiveness of Sofosbuvir/Velpatasvir in Treating Hepatitis C Virus Infections in Real-World Setting
Loss to follow-up Among Hepatitis C Infected Patients Treated with Direct Acting Antiviral Agents
Factors Associated with HBV, HCV and HIV Infection in British Columbia, Canada Differ by Ethnicity
Linkage with Liver Care Among People Living with Hepatitis C Virus Infection in British Columbia
Drug-related Deaths Among People Living with and without Hepatitis C in British Columbia (BC), Canada
Hepatitis C Virus Reinfection after Successful Treatment with Direct-acting Antiviral Therapy in a Large Population-based Cohort
Coinfections and Triple Infection with HCV, HBV and HIV Are Associated with Higher Mortality Risk in a Large Population Based Cohort Study
Impact of HCV Sustained Virologic Response on Liver and Drug-related Mortality in a Large Population Based Cohort
The Impact of HCV Sustained Virologic Response from Direct Acting Antiviral and Interferon-Based Treatments on Mortality in a Large Population Based Cohort Study
Sustained Virologic Responses Reduces the Incidence of Extrahepatic Manifestations in Chronic Hepatitis C Infection
Impact of Sequence of Diagnoses on All-Cause Mortality Among HBV/HCV Co-Infected Individuals: A Marker of Risk Stratification

Sep 12-14, 2018 International Population Data Linkage Network Conference (Banff, Alberta)

Differential spatial distribution of hepatitis B virus by ethnicity in British Columbia, Canada: Expanded role of a large administrative cohort

Jun 14-17,2018 Global Hepatitis Summit (Toronto, ON)

Hepatitis C Virus Reinfection after Successful Treatment with All-oral, Direct-Acting Antiviral Therapy in a large population-based cohort including people who inject drugs
Prevention and care cascade for hepatitis C among people who inject drugs in British Columbia, Canada
Syndemic Characterization of HCV< HBV< HIV Co-infection in a large population based cohort study
Characteristics of people diagnosed with acute and chronic hepatitis B virus infection differ by ethnicity
Lost to follow-up among Ledipasvir/sofosbuvir treated patients in Canada: The BC Hepatitis Testers Cohort

Apr 26-29, 2018 Canadian Conference on HIV/AIDS Research (Vancouver, BC)

Prevention and care cascade for hepatitis C among people who inject drugs in British Columbia, Canada
Identifying ‘core areas’ of HCV infection in British Columbia, Canada
Population-level cascade of care for hepatitis C in British Columbia: Differences over time, by gender and birth cohort
Population-level cascade of care for hepatitis C among people living with or without HIV infection
Differing profiles of people who diagnose with acute and chronic Hepatitis B virus infection: A large population based study

Apr 11-15, 2018 53rd Annual International Liver Congress, organized by the European Association for the Study of the Liver (EASL) (Paris, France)

Trends in decompensated cirrhosis and hepatocellular carcinoma in people with and without hepatitis C in British Columbia
Hepatitis C virus reinfection after successful treatment with all-oral direct-acting antiviral therapy in British Columbia, Canada

Mar 20-24, 2018 International Workshop on HIV And Hepatitis Observational Databases (Fuengirola, Spain)

Trends in decompensated cirrhosis and hepatocellular carcinoma in people with and without hepatitis C in British Columbia
Prevention and care cascade for hepatitis C among people who inject drugs in British Columbia, Canada

Feb 7-11, 2018 Canadian Liver Meeting (Toronto, ON)

Real-world effectiveness of sobosbuvir- based regimens for treatment among people who inject drugs and those in Opioid substitution therapy in Canada
Real-world effectiveness of sobosbuvir-based regimens for treatment of Hepatitis C Genotypes 1-3: BC Hepatitis Testers Cohort (BCHTC)
Spatial analysis of HCV infection in British Columbia
Reduced risk of HCV seroconversion among individuals undergoing psychotherapy: A population based retrospective cohort of multi-testers 1992-2013
What is killing people with HCV infection? Analysis of population based cohort in Canada
Population –level cascade of care for hepatitis C in British Columbia: Differences over time, by gender and birth cohort.

2017

Nov 23-24, 2017 CATIE Forum (Toronto, ON)

What will it take: Eliminating Hepatitis 2030
Ethnic Differences in Hepatitis in Hepatitis C Epidemiology and Care Cascade

Oct 20-24, 2017 AASLD Annual Liver Meeting (Washington, D.C.)

Real-world Effectiveness of Sofosbuvir-based Regimens for Hepatitis C Treatment among People who Inject Drugs and those in Opoid substitution Therapy in Canada
Real-world effectiveness of Sofosbuvir-based Regimens for Treatment of Hepatitis C Genotypes 1-3: BC Hepatitis Testers Cohort (BCHTC)
Adherence to sofosbuvir and ledipasvir-sofosbuvir in British Columbia
What is Killing People with HCV infection? Analysis of population based cohort in Canada

Sep 6-8, 2017 International Symposium on Hepatitis Care in Substance Users (INSHU) (New Jersey, USA)

Hepatitis C Virus (HCV) Mortality attribution by Birth Cohort: British Columbia Hepatitis Testers Cohort (BCHTC)

May 14-17, 2017 Harm Reduction Conference (Montreal, QC)

Hepatitis C treatment aces to direct-acting antivirals among people who inject drugs and are on opioid substitution therapy

Apr 19-23, 2017 International Liver Congress (Amsterdam, Netherlands)

Are DAAs reducing barrier for HIV co-infected and people who inject drugs? A population based cohort study
The impact of sustained virological response on long term risk of decompensated cirrhosis: The BC Hepatitis Testers Cohort

Apr 6-9, 2017 Canadian Association for HIV Research (Montreal, QC)

The impact of sustained virological response on long term risk of decompensated cirrhosis: The BC Hepatitis Testers
Shift in disparities in Hepatitis C treatment from interferon to DAA era: A population-based cohort study.
Factors determining HIV risk among HCV infected individuals: The British Columbia Hepatitis Testers Cohort (BC-HTC)
Impact of drug use and opioid substitution therapy on hepatitis C reinfection: The BC Hepatitis Testers Cohort
Re-clearance of hepatitis C: Role of previous clearance and reinfection with a heterologous genotype
Effect of OST and psychotherapy on HIV risk among HCV infected individuals
Size Estimate of Key Populations who are at Risk of Acquiring HIV and HCV in British Columbia.
Social disparities and co-evolution of HIV/HCV infections, mental disorders and substance use: the British Columbia Hepatitis Testers Cohort.
Interdisciplinary Approach to Developing a Hepatitis C Testing Guide – Responding to the Needs of Local Physicians
HIV diagnosis on first test and infection stage among HIV positive visible minority MSM in BC.
A syndemic approach to assess the effect of substance Use and social disparities on the evolution of HIV/HCV infections in British Columbia
Spatial and temporal trends of HIV and HCV diagnoses in British Columbia

Mar 3-6, 2017 6^th Canadian Association of Study of Liver’s Canadian Digestive Disease Week (CDDW) (Banff, AB)

Shift in disparities in Hepatitis C treatment from interferon to DAA era: A population-based cohort study

Mar 3, 2017 6^th Canadian Symposium on Hepatitis C Virus (Banff, AB)

Impact of treatment induced vs. spontaneous HCV clearance on the long term risk of hepatocellular carcinoma: BC Hepatitis Testers Cohort

Feb 13-16, 2017 Conference on Retroviruses and Opportunistic Infections (Seattle, WA)

Effect of OST and psychotherapy on HIV risk among HCV infected individuals
Risk profiles in mono infected TB patients and those co-infected with HCV and/or HIV

2016

Nov 11-15, 2016 AASLD Annual Liver Meeting (Boston, MA)

Role of primary T-cell immunodeficiency and Hepatitis B co-infection on spontaneous clearance of Hepatitis C: The BC Hepatitis Testers Cohort
Impact of drug use and opioid substitution therapy on hepatitis C reinfection
Long-term effect of sustained virological response on hepatocellular carcinoma risk in Canadians with hepatitis C virus infection
Re-clearance of hepatitis C: Role of previous clearance and reinfection with a heterologous genotype
Social disparities and co-evolution of HIV/HCV infections, mental disorders and substance use: the British Columbia Hepatitis Testers Cohort
Impact of treatment induced vs spontaneous HCV clearance on the long term risk of hepatocellular carcinoma: BC Hepatitis Testers Cohort

May 12-15, 2016 Canadian Association for HIV Research (Winnipeg, MB)

The British Columbia Hepatitis Testers Cohort
Assessing Injection Drug Use from Diagnostic Codes in Administrative Healthcare Data: the British Columbia Hepatitis Testers Cohort
Timing of Hepatitis B and C Diagnosis Relative to Hepatocellular Carcinoma Diagnosis in the BC Hepatitis Testers Cohort (BC-HTC)

Apr 13-17, 2016 International Liver Congress (Barcelona, Spain)

The BC Hepatitis Testers Cohort: The Population Level Hepatitis C Cascade of Care in British Columbia, Canada
Does alcohol dependency explain differences in rates of decompensated cirrhosis among people with a hepatitis C notification? An international comparison

Mar 30-Apr 2, 2016 AMMI Canada - CACMID Annual Conference (Vancouver, BC)

Hepatitis C Virus (HCV) Mortality Patterns in the British Columbia Hepatitis Testers Cohort (BC-HTC)

Feb 26, 2016 5^th Canadian Symposium on HCV (Montréal, QC)

The BC Hepatitis Testers Cohort (BC-HTC): the population-level hepatitis C Cascade of Care, BC, Canada, 1992-2012

2015

Nov, 17 2015 AASLD Annual Liver Meeting (San Francisco, CA)

Hepatitis C Virus (HCV) Mortality Patterns in the British Columbia Hepatitis Testers Cohort (BC-HTC)
Timing of Hepatitis B and C Diagnosis Relative to Hepatocellular Carcinoma Diagnosis in the BC Hepatitis Testers Cohort (BC-HTC)

May, 29 2015 Hepatology Update (Toronto, ON)

The Epidemiology of HCV in Canada

Apr, 28 2014 International Health Data Linkage Conference (Vancouver, BC)

British Columbia Hep C-HIV Testers Cohort: A Linkage to Monitor Hepatitis C-Related Outcomes

Poster Presentations

2020

Feb 28-Mar 1, 2020 Canadian Liver Meeting (Montreal, QC)

A population-level latent class analysis of people living with hepatitis C virus for effective program planning and health care resource distribution (Poster)
Treatment differential in HCV treatment prescribers in British Columbia over time (Poster)
Ethnic disparities in the risk of hepatitis C virus-related diabetes in a large population-based cohort in Canada (Poster)
Syndemic of viral co-infections and incident end-stage renal disease (Poster)
Trends in hepatocellular carcinoma survival among individuals infected with HBV and/or HCV in British Columbia, Canada (2001-2016) (Poster)
Association between prescription opioids and Hepatitis C virus seroconversion among people who use injection drugs in British Columbia (Poster)
Current Opioid Agonist Therapy is associated with hepatitis C virus treatment uptake among People Who Inject Drugs in a population based data linkage study(Poster)
Hepatitis C virus reinfection after successful treatment with direct acting antiviral therapy in Canada (Poster)
Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment (Poster)
Geographic distribution of people living with hepatitis C in British Columbia: an application of latent class analysis and disease mapping (Poster)
Frequency of Prenatal Hepatitis C Screening and Diagnoses in British Columbia, 2008-2018 (Poster)

2019

Nov 9-12, 2019 American Association for the Study of Liver Disease (Boston, MA)

- Characterization and identification of gaps within the HCV cascade of care among ethnic groups: a population-based cohort study (Poster)
- Effectiveness of sofosbuvir / velpatasvir in treating hepatitis C virus infection in a real- world setting (Poster)
- Real-world effectiveness of sofosbuvir /velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment (Poster)
- Liver-related death among chronic hepatitis B patients initiating tenofovir, entecavir or lamivudine treatment in British Columbia (Poster)
- Hepatitis C Virus Reinfection after Successful Treatment with Direct-Acting Antiviral Therapy among MSM (Poster)

</
Sep 11-13, 2019 8th International Conference on Hepatitis Care in Substance Users (Montreal, QC)

- - Association between prescription opioids and Hepatitis C virus seroconversion among people who use injection drugs in British Columbia (Poster)
  - Geographic cascade of HCV care: A tool for targeted interventions and program evaluation (Poster)

Aug 5-6, 2019 Australasian Viral Hepatitis Elimination Conference (Sydney, Australia)

- - Hepatitis C virus treatment uptake differs according to recency of opioid agonist therapy among people who inject drugs with chronic hepatitis C infection (Poster)

Jul 14-17, 2019 23rd International Society for Sexually Transmitted Diseases Research (Vancouver, BC)

- - MSM predictive modeling within a large, linked database of laboratory, surveillance, and administrative healthcare records (Poster)
  - Evolution of Hepatitis C cascades of care among HIV and hepatitis B co-infected patients in British Columbia, Canada (Poster)
  - Elevated HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men (Poster)
  - Cancer Risk Among People with HIV, HBV and/or HCV Infections (Poster)

May 24-26, 2019 Canadian Liver Meeting (Montreal, QC)

- - Elevated HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men (Poster)
  - Spatio-temporal detection of HCV reinfection clusters: an approach to inform interventions for prevention of reinfection (Poster)
  - Characterization and identification of gaps within the HCV cascade of care among ethnic minority groups: a population-based cohort study (Poster)
  - Hepatitis C cascade of care and factors associated with treatment uptake among people who inject drugs in British Columbia in 2017 (Poster)
  - Hepatitis C incidence rate among people who inject drug (PWID) in British Columbia from 2000 to 2015 (Poster)

May 9-12, 2019 28th Annual Canadian Conference on HIV/AIDS Research (Saskatoon, SK)

- - The impact of HCV SVR from direct acting antiviral and interferon-based treatments on mortality in a large population based cohort study (Poster)
  - Drug-related deaths among hepatitis C positive and negative people in British Columbia, Canada (Poster)

Apr 10-14, 2019 54th Annual International Liver Congress, organized by the European Association for the Study of the Liver (Vienna, Austria)

- - Factors associated with hepatitis C treatment uptake among people who inject drugs in a population-based data linkage study (Poster)
  - The impact of HCV SVR from direct acting antiviral and interferon-based treatments on HCC in a large population based cohort study (Poster)
  - Cancer Risk Among People with HIV, HBV and/or HCV Infections (Poster)
  - Elevated HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men (Poster)

Mar 4-7, 2019 Conference on Retroviruses and Opportunistic Infections (Seattle, WA)

- - Hepatitis C cascade of care among people who inject drugs in British Columbia in 2017 (Poster)

Feb 26-28, 2019 BC Quality Forum

- - Integrating health and administrative datasets to improve quality of care: The BC-HTC (Poster)

2018

Apr 27-29 2018 Canadian Association for HIV Research (Vancouver, BC)

- - Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection: a large population based study
  - Population-level cascade of care for Hepatitis C in British Columbia: Differences over time, by gender and birth cohort

Mar 22-2 2018 International Workshop on HIV and Hepatitis Observational Databases (Fuengirola, Spain)

- - Trends in decompensated cirrhosis and hepatocellular carcinoma in people with and without hepatitis C in British Columbia
  - Prevention and care cascade for hepatitis C among people who inject drugs in British Columbia, Canada

Feb 9-11 2018 Canadian Liver Meeting (Toronto, On)

- - Real-world Effectiveness of Sofosbuvir-based regimens for Treatment of Hepatitis C Genotypes 1-3: BC Hepatitis Testers Cohort (BC-HTC)
  - Spatial analysis of HCV infection in British Columbia, Canada
  - What is Killing People with HCV Infection? Analysis of a population-based cohort in Canada
  - Psychotherapy reduces the risk of HCV Sero-conversion among multi-testers from BC Hepatitis testers cohort

2017

Oct 20-24 2017 AASLD Annual Liver Meeting (Washington, D.C)

- - Real-world Effectiveness of Sofosbuvir-based regimens for Hepatitis C Treatment among People who inject Drugs and those in Opioid substitution Therapy in Canada
  - Real-world Effectiveness of Sofosbuvir-based Regimens for treatment of Hepatitis C Genotypes 1-3: BC Hepatitis Testers Cohort (BCHTC)
  - Adherence to sofosbuvir and ledipasvir-sofosbuvir in British Columbia
  - What is Killing People with HCV infection? Analysis of population based cohort in Canada

Sept 6-8, 2017 International Symposium on Hepatitis Care in Substance Users (INSHU) (New Jersery, USA)

- - Hepatitis C Virus (HCV) Mortality attribution by birth cohort: British Columbia Hepatitis Testers Cohort (BCHTC)

May 14-17, 2017 Harm Reduction Conference (Montreal,QU)

- - Hepatitis C treatment access to direct-acting antivirals among people who inject drugs and are on opioid substitution therapy

Apr 6-9^th 2017 Canadian Association for HIV Research (Montreal,QU)

- - Hepatitis C re-clearance and lack of cross-genotype immunity in a large population cohort
  - Spatial and temporal trends of HIV and HCV diagnoses in British Columbia

Feb 13-16, 2017 Conference on Retrovirus and Opportunistic Infections (Seattle, WA)

- - Effects of OST and psychotherapy on HIV risk among HCV infected individuals
  - Risk profiles in mono infected TB patients and those co-infected with HCV and/or HIV

2016

Dec 6-8th, 2016 Canadian Immunization Conference (Ottawa)

- - Variable effects of Repeat Vaccination against Influenza b Illness by Season 2010-11 to 2014-15

Nov 11-15,2016 AASLD Annual Liver Meeting (Boston, MA)

- - Role of primary T-cell immunodeficiency and Hepatitis B co-infection on spontaneous clearance of Hepatitis C: The BC Hepatitis Testers Cohort
  - Re-clearance of hepatitis C: Role of previous clearance and reinfection with a heterologous genotype
  - Social disparities and co-evolution of HIV/HCV infections,mental disorders and substance use: the British Columbia Hepatitis Testers Cohort
  - Impact of treatment induced vs spontaneous HCV clearance on the long term risk of hepatocellular carcinoma; BC Hepatitis Testers Cohort View Poster

May 12-15, 2016 – Canadian Association for HIV Research (Winnipeg, MB)

- - Assessing Injection Drug Use from Diagnostic Codes in Administrative Healthcare Data: the British Columbia Hepatitis Testers Cohort

Feb, 26 2016 5^th Canadian Symposium on HCV (Montréal, QC)

- - The BC Hepatitis Testers Cohort (BC-HTC): the population-level hepatitis C Cascade of Care, BC, Canada, 1992-2012

2015

Mar 2, 2015 Canadian Association for the Study of the Liver (Banff, AB)

- - Hepatitis C Epidemiology in British Columbia to Inform Screening and Treatment Response